Cargando…
Selenium supplementation in patients with peripartum cardiomyopathy: a proof-of-concept trial
BACKGROUND: We studied the efficacy and safety of selenium supplementation in patients who had peripartum cardiomyopathy (PPCM) and selenium deficiency. METHODS: We randomly assigned 100 PPCM patients with left ventricular ejection fraction (LVEF) < 45% and selenium deficiency (< 70 μg/L) to r...
Autores principales: | Karaye, Kamilu M., Sa’idu, Hadiza, Balarabe, Suleiman A., Ishaq, Naser A., Sanni, Bushra, Abubakar, Haruna, Mohammed, Baba Lawan, Abdulsalam, Tijjani, Tukur, Jamilu, Mohammed, Idris Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579991/ https://www.ncbi.nlm.nih.gov/pubmed/33087055 http://dx.doi.org/10.1186/s12872-020-01739-z |
Ejemplares similares
-
Correction to: Selenium supplementation in patients with peripartum cardiomyopathy: a proof‑of‑concept trial
por: Karaye, Kamilu M., et al.
Publicado: (2021) -
Disparities in clinical features and outcomes of peripartum cardiomyopathy in high versus low prevalent regions in Nigeria
por: Karaye, Kamilu M., et al.
Publicado: (2021) -
Serum Selenium and Ceruloplasmin in Nigerians with Peripartum Cardiomyopathy
por: Karaye, Kamilu M., et al.
Publicado: (2015) -
Right ventricular dysfunction in a hypertensive population stratified by patterns of left ventricular geometry
por: Karaye, Kamilu M, et al.
Publicado: (2012) -
Electrocardiographic predictors of peripartum cardiomyopathy
por: Karaye, Kamilu M, et al.
Publicado: (2016)